Clinical Trials List
2024-10-30 - 2026-12-31
Phase II
Recruiting6
ICD-10I50.20
Unspecified systolic (congestive) heart failure
ICD-10I50.21
Acute systolic (congestive) heart failure
ICD-10I50.22
Chronic systolic (congestive) heart failure
ICD-10I50.23
Acute on chronic systolic (congestive) heart failure
ICD-10I50.30
Unspecified diastolic (congestive) heart failure
ICD-10I50.31
Acute diastolic (congestive) heart failure
ICD-10I50.32
Chronic diastolic (congestive) heart failure
ICD-10I50.33
Acute on chronic diastolic (congestive) heart failure
ICD-10I50.40
Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.41
Acute combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.42
Chronic combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.43
Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.9
Heart failure, unspecified
ICD-9428.0
Congestive heart failure
-
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/15
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳韋璁 Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Po-Tseng Lee Division of Cardiovascular Diseases
- 黃睦翔 Division of Cardiovascular Diseases
- 柯呈諭 Division of Cardiovascular Diseases
- 黃鼎鈞 Division of Cardiovascular Diseases
- 張獻元 Division of Cardiovascular Diseases
- 李文煌 Division of Cardiovascular Diseases
- Po-Sheng Chen Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Ju Wu Division of Cardiovascular Diseases
- 簡育珊 Division of Cardiovascular Diseases
- 王奇彥 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林重佑 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHO-KAI WU Division of Cardiovascular Diseases
- 賀立婷 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
240 participants
